Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06JUR
|
||||
Former ID |
DNC003668
|
||||
Drug Name |
Rogletimide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Terminated | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C12H14N2O2
|
||||
Canonical SMILES |
CCC1(CCC(=O)NC1=O)C2=CC=NC=C2
|
||||
InChI |
1S/C12H14N2O2/c1-2-12(9-4-7-13-8-5-9)6-3-10(15)14-11(12)16/h4-5,7-8H,2-3,6H2,1H3,(H,14,15,16)
|
||||
InChIKey |
QXKJWHWUDVQATH-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 121840-95-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [2] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Estradiol biosynthesis II | |||||
Estradiol biosynthesis I | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
Ovarian steroidogenesis | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001207) | ||||
REF 2 | J Med Chem. 1987 Sep;30(9):1550-4.Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.